GGrantIndex
Sort

17,828 grants matching crispr

Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors

$399,380
Jessica Jiyeong Lin · Massachusetts General Hospital · R01 · FY2021 · CA

Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors

$399,380
Alice T Shaw · Massachusetts General Hospital · R01 · FY2017 · CA

Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors

$399,380
Alice T Shaw · Massachusetts General Hospital · R01 · FY2018 · CA

The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapy

$399,379
Benjamin Izar · Columbia University Health Sciences · R01 · FY2023 · CA

A Uniquely Scalable Approach to Single Cell Sequencing for the Development of Next Generation Cell Therapies

$399,369
Philipp Stefan Spuhler · Sansimeon, Inc · R43 · FY2024 · HG

Regulation of Lens Fiber Cell Structure and Function by Post Translational Modification of Intermediate Filaments

$399,339
Paul G Fitzgerald · University Of California At Davis · R01 · FY2017 · EY

Project 3: Systematic characterization of factors controlling breast cancer progression and resistance

$399,288
Michael C Bassik · Stanford University · U54 · FY2022 · CA

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258
Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2019 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258
Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2020 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258
Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2022 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258
Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2021 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258
Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2018 · GM

Molecular determinants of neuronal protein homeostasis through plasma membrane-localized proteasome complexes.

$399,181
Kapil Ramachandran · Columbia University Health Sciences · DP5 · FY2023 · OD

Ethical Issues Surrounding Human Germline Genome Editing

$399,165
Kathleen M Vogel · University Of Maryland, College Park · · FY2019 · SBE

Toxoplasma proteins that modulate the host cell

$399,144
Jeroen Saeij · University Of California At Davis · R01 · FY2017 · AI

Characterizing the Molecular Basis of Supergene Mimicry in Butterflies

$399,064
Marcus Kronforst · University Of Chicago · R35 · FY2020 · GM

Characterizing the Molecular Basis of Supergene Mimicry in Butterflies

$399,064
Marcus Kronforst · University Of Chicago · R35 · FY2023 · GM

Characterizing the Molecular Basis of Supergene Mimicry in Butterflies

$399,064
Marcus Kronforst · University Of Chicago · R35 · FY2022 · GM

Characterizing the Molecular Basis of Supergene Mimicry in Butterflies

$399,064
Marcus Kronforst · University Of Chicago · R35 · FY2021 · GM

Characterizing the Molecular Basis of Supergene Mimicry in Butterflies

$399,064
Marcus Kronforst · University Of Chicago · R35 · FY2019 · GM

Biology and therapeutic targeting of zinc finger transcription factors in AML

$399,061
Scott A Armstrong · Dana-Farber Cancer Inst · P01 · FY2021 · CA

Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor Cells

$399,000
Daniel A. Haber · Massachusetts General Hospital · R01 · FY2024 · CA

Network-based prediction and validation of causal schizophrenia genes and variants

$398,936
Manolis Kellis · Massachusetts Institute Of Technology · R01 · FY2019 · MH

Validating novel DNA repair deficient cancer therapy targets and small molecule compounds

$398,917
Steven Monroe Lipkin · Ananeo Therapeutics Inc. · R41 · FY2022 · CA

Atlanta Center for the Childhood Liver Disease Research Network (ChiLDReN)

$398,899
Saul Joseph Karpen · Emory University · U01 · FY2020 · DK